May 7, 2020 07:29 AM EDT

Stepping on BioMarin's turf, PTC Therapeutics picks up PKU drug for a song

Amber Tong

While industry-shaking M&A deals are still nowhere in sight, smaller deals by bargain shoppers continue to trickle in. PTC Therapeutics has joined the club, bagging …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Stepping on BioMarin's turf, PTC Therapeutics picks up PKU drug for a song

Amber Tong

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

Exclusive: Flagship-backed Valo Health loses interim CEO ahead of key Phase 2 readout

Edgewise’s stock surges as heart drug passes early safety test

FDA inspectors discover trucks carrying torn-up records leaving Indian generics factory

Stem cell startup spun out of George Church’s lab raises $75M

Lasker Award goes to three scientists who pioneered research behind GLP-1 drugs

Breaking down silos with a new quantitative approach to drug development

Step­ping on Bio­Mar­in's turf, PTC Ther­a­peu­tics picks up PKU drug for a song

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Stepping on BioMarin's turf, PTC Therapeutics picks up PKU drug for a song